Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
Public ClinicalTrials.gov record NCT02978222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Multicenter Phase II Trial to Evaluate the Safety, Efficacy and Immunogenicity of Vaccination With Folate Receptor Alpha Peptides With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer and a Response or Stable Disease to Platinum Therapy
Study identification
- NCT ID
- NCT02978222
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Marker Therapeutics, Inc.
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- FRα peptide plus Adjuvant (GM-CSF) Biological
- Adjuvant (GM-CSF) Alone Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 19, 2017
- Primary completion
- Jan 14, 2020
- Completion
- Jan 14, 2020
- Last update posted
- Dec 14, 2022
2017 – 2020
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Gynecology Oncology | Birmingham | Alabama | 35233 | — |
| Mayo Clinic Cancer Center | Phoenix | Arizona | 85054 | — |
| Women's Cancer Research Foundation | Newport Beach | California | 92663 | — |
| The Stamford Hospital/Bennett Cancer Center | Stamford | Connecticut | 06904 | — |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | — |
| Mt. Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Florida Cancer Specialist | West Palm Beach | Florida | 33401 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Research Partners | Jackson | Mississippi | 39202 | — |
| MidAmerica Division, Inc. c/o Research Medical Center | Kansas City | Missouri | 64132 | — |
| University Of New Mexico Comprehensive Cancer Center | Albuquerque | New Mexico | 87102 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Hematology/Oncology Lenox Hill Hospital | New York | New York | 10075 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| OHSU | Portland | Oregon | 97239 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001 | — |
| Tennessee Oncology/Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02978222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2022 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02978222 live on ClinicalTrials.gov.